{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:08:39Z","timestamp":1760659719922,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118446","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T04:23:06Z","timestamp":1755058986000},"page":"118446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicity"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1467-8635","authenticated-orcid":false,"given":"Hugo","family":"Tejera-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6037-6251","authenticated-orcid":false,"given":"Alejandro","family":"Velasco-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"N\u00fa\u00f1ez-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2393-0510","authenticated-orcid":false,"given":"Guillermo","family":"Pita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Rosario","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Herr\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4353-4008","authenticated-orcid":false,"given":"Carla","family":"Cortina-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Puig-Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Torres-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Rodriguez-Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ricart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Ma\u00f1osa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Dolores","family":"Mart\u00edn-Arranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamile","family":"Zabana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Guardiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4982-2529","authenticated-orcid":false,"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Piqueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-1072","authenticated-orcid":false,"given":"Alfredo J.","family":"Lucendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7632-0340","authenticated-orcid":false,"given":"Ingrid","family":"Ord\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margalida","family":"Calafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeni","family":"Dom\u00e8nech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-2020","authenticated-orcid":false,"given":"Anna","family":"Gonzalez-Neira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118446_bib1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1572-0241.2008.01848.x","article-title":"Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118446_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115706","article-title":"Azathioprine dose tailoring based on pharmacogenetic information: insights of clinical implementation","volume":"168","author":"D\u00edaz-Villamar\u00edn","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118446_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.118446_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat. Genet"},{"key":"10.1016\/j.biopha.2025.118446_bib5","article-title":"Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with european ancestry","volume":"0","author":"Schaeffeler","year":"2019","journal-title":"Genet. Med"},{"key":"10.1016\/j.biopha.2025.118446_bib6","first-page":"1","article-title":"TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India","author":"Grover","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118446_bib7","article-title":"Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn\u2019s disease patients","volume":"24","author":"Salazar","year":"2024","journal-title":"Pharm. J."},{"key":"10.1016\/j.biopha.2025.118446_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12967-020-02416-7","article-title":"Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT","volume":"18","author":"Park","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118446_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/FTD.0b013e31824aa681","article-title":"Polymorphism of genes involved in purine metabolism (XDH, AOX1, MOCOS) in kidney transplant recipients receiving azathioprine","volume":"34","author":"Kurzawski","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.biopha.2025.118446_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bjh.18405","article-title":"Prominence of NUDT15 genetic variation associated with 6-mercaptopurine tolerance in a genome-wide association study of Japanese children with acute lymphoblastic leukaemia","volume":"199","author":"Tanaka","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2025.118446_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00535-018-1486-7","article-title":"NUDT15codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study","volume":"53","author":"Kakuta","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118446_bib12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1136\/gutjnl-2016-311921","article-title":"A coding variant in FTO confers susceptibility to thiopurine-induced leukopenia in east asian patients with IBD","volume":"66","author":"Kim","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2025.118446_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jama.2019.0709","article-title":"Association of genetic variants in NUDT15 with Thiopurine-Induced myelosuppression in patients with inflammatory bowel disease","volume":"321","author":"Walker","year":"2019","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.biopha.2025.118446_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ng.3060","article-title":"A common missense variant in NUDT15confers susceptibility to thiopurine-induced leukopenia","volume":"46","author":"Yang","year":"2014","journal-title":"Nat. Genet"},{"key":"10.1016\/j.biopha.2025.118446_bib15","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1093\/hmg\/dds302","article-title":"PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity","volume":"21","author":"Stocco","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.118446_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/pgs.13.38","article-title":"New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients","volume":"14","author":"Zabala","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.biopha.2025.118446_bib17","doi-asserted-by":"crossref","unstructured":"E.W. Chua, S. Cree, M.L. Barclay, K. Doudney, K. Lehnert, A. Aitchison, M.A. Kennedy, Exome Sequencing and Array-based Comparative Genomic Hybridisation Analysis of Preferential 6-methylmercaptopurine Producers, (2015) 1\u20138. https:\/\/doi.org\/10.1038\/tpj.2015.9.","DOI":"10.1038\/tpj.2015.9"},{"key":"10.1016\/j.biopha.2025.118446_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-018-0157-3","article-title":"Integrating rare genetic variants into pharmacogenetic drug response predictions","volume":"12","author":"Ingelman-Sundberg","year":"2018","journal-title":"Hum. Genom."},{"key":"10.1016\/j.biopha.2025.118446_bib19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1517\/17425255.2014.903239","article-title":"Considerations for rare variants in drug metabolism genes and the clinical implications","volume":"10","author":"Dr\u00f6gem\u00f6ller","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.biopha.2025.118446_bib20","first-page":"551","article-title":"The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: design, monitoring and functions, gastroenterol. Hepatol","volume":"43","author":"Zabana","year":"2020"},{"key":"10.1016\/j.biopha.2025.118446_bib21","first-page":"1","article-title":"An Evidence-Based framework for evaluating pharmacogenomics knowledge for personalized Medicine","volume":"0","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.118446_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/FPC.0b013e328334338f","article-title":"Thiopurine pathway","volume":"20","author":"Zaza","year":"2010","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.biopha.2025.118446_bib23","doi-asserted-by":"crossref","first-page":"W589","DOI":"10.1093\/nar\/gkv350","article-title":"The BioMart community portal: an innovative alternative to large, centralized data repositories","volume":"43","author":"Smedley","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118446_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2025.118446_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajhg.2011.03.004","article-title":"Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, condel","volume":"88","author":"Gonz\u00e1lez-P\u00e9rez","year":"2011","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.biopha.2025.118446_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118446_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41592-019-0430-y","article-title":"Trackviewer: a bioconductor package for interactive and integrative visualization of multi-omics data","volume":"16","author":"Ou","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2025.118446_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ajhg.2012.06.007","article-title":"Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies","volume":"91","author":"Lee","year":"2012","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.biopha.2025.118446_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1004219","article-title":"MAGMA: generalized Gene-Set analysis of GWAS data","volume":"11","author":"de Leeuw","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.biopha.2025.118446_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ajhg.2013.04.015","article-title":"Sequence kernel association tests for the combined effect of rare and common variants","volume":"92","author":"Ionita-Laza","year":"2013","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.biopha.2025.118446_bib31","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jama.2019.0709","article-title":"Association of genetic variants in NUDT15 with Thiopurine-Induced myelosuppression in patients with inflammatory bowel disease","volume":"321","author":"Walker","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118446_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17512433.2021.1900729","article-title":"Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a south asian region-specific systematic review and meta-analysis","volume":"14","author":"Jena","year":"2021","journal-title":"Expert Rev. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118446_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41576-019-0177-4","article-title":"Rare-variant collapsing analyses for complex traits: guidelines and applications","volume":"20","author":"Povysil","year":"2019","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.biopha.2025.118446_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2023.1159307","article-title":"Genetic variants of genes involved in thiopurine metabolism pathway are associated with 6-mercaptopurine toxicity in pediatric acute lymphoblastic leukemia patients from Ethiopia","volume":"14","author":"Ali","year":"2023","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118446_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2036.2009.04057.x","article-title":"Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease","volume":"30","author":"Smith","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.118446_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2125.2008.03248.x","article-title":"Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine","volume":"66","author":"Hawwa","year":"2008","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118446_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines9111723","article-title":"Association of mutations identified in xanthinuria with the function and inhibition mechanism of xanthine oxidoreductase","volume":"9","author":"Sekine","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118446_bib38","doi-asserted-by":"crossref","unstructured":"L.D. Fang-, H. Liu, X. Gao, L.H. Xue-, W. Bai-, Y. Zhang, C. Lv, P.- Hu, M. Huang, Xanthine Oxidase Activity in Thiopurine Curative Chinese Inflammatory Bowel Disease Patients, (2021) 1\u20138. https:\/\/doi.org\/10.1002\/prp2.764.","DOI":"10.1002\/prp2.764"},{"key":"10.1016\/j.biopha.2025.118446_bib39","first-page":"987","article-title":"[Hematotoxicity caused by azathioprine genetically determined and aggravated by xanthine oxidase deficiency in a patient following renal transplantation]","volume":"24","author":"Serre-Debeauvais","year":"1995","journal-title":"Presse Med."},{"key":"10.1016\/j.biopha.2025.118446_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.taap.2018.06.015","article-title":"Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II)","volume":"353","author":"Stiburkova","year":"2018","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2025.118446_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RHU.0000000000000838","article-title":"Beware of the uric acid","volume":"00","author":"Tanev","year":"2018","journal-title":"JCR J. Clin. Rheuma"},{"key":"10.1016\/j.biopha.2025.118446_bib42","doi-asserted-by":"crossref","first-page":"15475","DOI":"10.3390\/ijms131115475","article-title":"Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans","volume":"13","author":"Ichida","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118446_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2011.04905.x","article-title":"Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease","volume":"35","author":"Chouchana","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.118446_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.crohns.2012.02.007","article-title":"Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol","volume":"6","author":"Smith","year":"2012","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.biopha.2025.118446_bib45","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000358147","article-title":"Are we using and monitoring thiopurines and biologics optimally?","volume":"32","author":"Irving","year":"2014","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biopha.2025.118446_bib46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.15458","article-title":"ENEIDA registry of GETECCU, increased risk of thiopurine-related adverse events in elderly patients with IBD","volume":"50","author":"Calafat","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.118446_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.gastrohep.2017.11.007","article-title":"Recomendaciones del grupo Espa\u00f1ol de trabajo en enfermedad de crohn y colitis ulcerosa (GETECCU) sobre el uso de tiopurinas en la enfermedad inflamatoria intestinal","volume":"41","author":"Bermejo","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118446_bib48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cca.2020.02.012","article-title":"A novel mutation in xanthine dehydrogenase in a case with xanthinuria in hunan province of China","volume":"504","author":"Xu","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2025.118446_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep34658","article-title":"Genes implicated in thiopurine-induced toxicity: comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort","volume":"6","author":"Coelho","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118446_bib50","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.arcped.2015.09.003","article-title":"Xanthinurie h\u00e9r\u00e9ditaire de type 1: \u00c0 propos de trois cas","volume":"22","author":"Diss","year":"2015","journal-title":"Arch. Pedia"},{"key":"10.1016\/j.biopha.2025.118446_bib51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2006.02.134","article-title":"Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines","volume":"343","author":"Fotoohi","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.118446_bib52","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.leukres.2007.09.015","article-title":"Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine","volume":"32","author":"Peng","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.biopha.2025.118446_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbrc.2011.06.120","article-title":"The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells","volume":"411","author":"Karim","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.118446_bib54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature25186","article-title":"Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia","volume":"553","author":"Tzoneva","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118446_bib55","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1124\/mol.62.6.1321","article-title":"Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells","volume":"62","author":"Wielinga","year":"2002","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118446_bib56","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-07-6790","article-title":"Transporter-mediated protection against thiopurine-induced hematopoietic toxicity","volume":"68","author":"Krishnamurthy","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118446_bib57","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00535-010-0248-y","article-title":"The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease","volume":"45","author":"Ban","year":"2010","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118446_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095080","article-title":"New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid","volume":"9","author":"Uchiyama","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118446_bib59","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1124\/dmd.110.035220","article-title":"Ecto-5\u2032-nucleotidase and thiopurine cellular circulation: association with cytotoxicity","volume":"38","author":"Li","year":"2010","journal-title":"Drug Metab. Dispos."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225006407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225006407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T02:38:01Z","timestamp":1760582281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225006407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":59,"alternative-id":["S0753332225006407"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118446","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118446"}}